Pamela MacTavish
Overview
Explore the profile of Pamela MacTavish including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
466
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McPeake J, MacTavish P, Puxty K, Crook C, Quasim T
Intensive Crit Care Nurs
. 2024 Dec;
87:103890.
PMID: 39733661
Background: Hospital readmission following critical illness is common. There is limited data which examines the patient and family perspective of hospital readmission. Understanding the impact of readmissions from a patient...
2.
Singer S, Betthauser K, Barber A, Bookstaver Korona R, Dixit D, Groth C, et al.
Hosp Pharm
. 2024 Nov;
59(6):650-659.
PMID: 39493571
Critical care pharmacists complete comprehensive medication reviews in Post Intensive Care Syndrome (PICS) patients at Intensive Care Unit Recovery Centers (ICU-RCs) to optimize medication therapies after hospital discharge. Inpatient pharmacists...
3.
Docherty C, Shaw M, Chim C, MacTavish P, Devine H, OBrien P, et al.
Chest
. 2024 Oct;
167(3):768-771.
PMID: 39368736
No abstract available.
4.
MacGregor F, Oprey A, Caulfield C, MacTavish P, Lowrie R, Henderson P
BMJ Open Respir Res
. 2024 Aug;
11(1).
PMID: 39214629
Background: The optimal timing of tocilizumab treatment during the disease course of COVID-19 has yet to be adequately defined in the context of randomised controlled trials and the effect of...
5.
Beaudrie-Nunn A, Poyant J, Groth C, Rappaport S, Kruer R, Miller E, et al.
Am J Health Syst Pharm
. 2024 Aug;
82(5):e262-e273.
PMID: 39162570
Purpose: To compare the incidence of ICU pharmacist interventions in intensive care unit recovery center (ICU-RC) in-person and virtual clinic visits. Methods: This was a post hoc analysis of interventions...
6.
Docherty C, Quasim T, MacTavish P, Devine H, OBrien P, Strachan L, et al.
Aust Crit Care
. 2024 May;
37(6):896-902.
PMID: 38797584
Background: Following critical illness, family members are often required to adopt caregiving responsibilities. Anxiety and depression are common long term problems for both patients and caregivers. However, at present, it...
7.
McPeake J, Iwashyna T, MacTavish P, Devine H, Henderson P, Quasim T, et al.
BJA Open
. 2024 Feb;
9:100259.
PMID: 38322488
Background: There is limited evidence to understand what impact, if any, recovery services might have for patients across the socioeconomic spectrum after critical illness. We analysed data from a multicentre...
8.
Andonovic M, Shaw M, Quasim T, MacTavish P, McPeake J
J Intensive Care Med
. 2023 Dec;
39(6):550-557.
PMID: 38087427
Background: Chronic opioid use represents a significant burden to global healthcare with adverse long-term outcomes. Elevated patient reported pain levels and analgesic prescriptions have been reported following discharge from critical...
9.
McPeake J, Castro P, Kentish-Barnes N, Cuzco C, Azoulay E, MacTavish P, et al.
Intensive Care Med
. 2023 Sep;
49(10):1203-1211.
PMID: 37698596
Purpose: The immediate impact of coronavirus disease 2019 (COVID-19) visiting restrictions for family members has been well-documented. However, the longer-term trajectory, including mechanisms for support, is less well-known. To address...
10.
Docherty C, McPeake J, Quasim T, MacTavish P, Devine H, OBrien P, et al.
J Crit Care
. 2023 Jun;
78:154359.
PMID: 37356416
Purpose: Survivors of critical illness frequently experience long-term symptoms including physical symptoms such as pain and emotional symptoms such as anxiety and depression. These symptoms frequently co-exist, however, at present...